메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Choi Ah-Ra (Department of Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, KoreaCollege of Nursing, Chonnam National University, Gwangju, Korea) Park Ki-Jeong (Department of Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, Korea) Kang Ji-Hyoun (Department of Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, Korea) Lee Yu Jeong (Department of Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, KoreaDepartment of Biomedical Sciences, Graduate School of Chonnam National University, Gwangju,) Jang Hyun Hee (Department of Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, Korea) Kim Moon-Ju (Department of Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, Korea) 김태종 (Department of Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, Korea)
저널정보
대한류마티스학회 대한류마티스학회지 Journal of Rheumatic Diseases Vol.31 No.3
발행연도
2024.7
수록면
171 - 177 (7page)
DOI
10.4078/jrd.2024.0029

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Objective: The purpose of this study is to evaluate the impact of tumor necrosis factor (TNF)-α blocker therapy on the Assessment of SpondyloArthritis international Society Health Index (ASAS-HI) among patients who have failed conventional nonsteroidal anti-inflammatory drugs. Methods: A comparative study was conducted involving axial spondyloarthritis (axSpA) patients treated with either TNF-α blocker or conventional therapy. Patient data, including demographics, disease characteristics, and ASAS-HI scores, were collected before and after treatment. Statistical analysis was performed to compare changes in ASAS-HI scores between the TNF-α blocker and the conventional therapy group. Results: The study population consisted of patients with axSpA, with a mean age of 38.3 years in conventional treatment group and 29.3 years in TNF-α blocker group. Most variables, including C-reactive protein levels, other comorbidities, and disease assessment scores showed no significant difference between groups. Longitudinal analysis within each treatment group from Week 0 to 12 showed no significant change in the conventional treatment group, whereas the TNF-α blocker group experienced a significant reduction in ASAS-HI scores, demonstrating the effectiveness of the treatment. The TNF-α blocker group exhibited a significantly greater improvement in ASAS-HI scores compared to the conventional therapy group. The Bath Ankylosing Spondylitis Functional Index and the Bath Ankylosing Spondylitis Disease Activity Index demonstrated strong positive correlations with ASAS-HI scores, indicating higher disease activity and functional limitation are associated with worse health outcomes in patients. Conclusion: The research demonstrates that ASAS-HI scores significantly improve with TNF-α blocker therapy in axSpA patients, underscoring ASAS-HI's effectiveness as a tool for evaluating drug responses.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

최근 본 자료

전체보기

댓글(0)

0